This site is part of the Siconnects Division of Sciinov Group

This site is operated by a business or businesses owned by Sciinov Group and all copyright resides with them.

ADD THESE DATES TO YOUR E-DIARY OR GOOGLE CALENDAR

Registration
Event
Hybrid Event

Accelerate Ideas, Partnerships and Opportunities

Book your SLOT NOW
  • Start 9:00am - 6:00pm
  • Rome, Italy
 

About Conference

Sciinov Group is proud to announce the Oligonucleotide Therapeutics and Delivery ConferenceSeptember 09-10, 2024 in Rome, Italy. This year OTDC 2024 annual Oligonucleotide Therapeutics and Delivery conference will showcase recent advances in oligonucleotide development, regulatory requirements and CMC considerations, strategies to enhance oligonucleotide discovery and targeting and optimised delivery techniques for oligonucleotide-based therapies, in the hope to continue to drive forward the field of oligonucleotide drug development. Join us on the September 09-10, 2024 at Rome, Italy.

Industry and academic experts deliver detailed case studies on ...

Readmore

Author's Login
Abstract Tracking Tool

ask & questions

answer

We are always looking for new industry leaders to join our speaker faculty to deliver presentations, lead panel discussions and moderate sessions or roundtables. 
If you are interested in being considered as a speaker, submit your proposal/abstract Online

answer

We let speakers propose the topic they want to talk about. This process allows speakers to propose sessions that speak from their expertise and passion.
Speaker can choose the topic of your choice in related to the conference subject or any of their recent research work to present at our conference.
For details of scientific sessions covered please visit [not limited to, you can propose]  

 

answer

Please visit the page here

answer

Yes, as our conference is scheduled in Hybrid Mode, you can present and listen to full program virtually connecting via ZOOM live stream


Recent Updates

16 JAN
2024

New RNA Therapeutics Core Facility to Drive Cutting-Edge Research

RNA-based technologies, such as the COVID-19 vaccine, are quickly advancing and hold promise to treat diseases ranging from inherited metabolic conditions and autoimmune disorders to cancer and cardiovascular disease.Readmore

21 FEB
2024

A new RNA editing tool could enhance cancer treatment

The new study found that an RNA-targeting CRISPR platform could tune immune cell metabolism without permanent genetic changes, potentially unveiling a relatively low-risk way to upgrade existing cell therapies for cancer.Readmore

22May
2024

Welcome to a brave new world of therapeutics

The field of RNA therapeutics has expanded incredibly over the last 30 years, and mRNA-based COVID-19 vaccines are just the start.Readmore

9th JAN
2024

New CRISPR Center Brings Hope for Rare and Deadly Genetic Diseases

CRISPR collaboration combines expertise from three UC schools to scale treatment for diseases that industry has largely passed by – until now.Readmore


08:00-09:00

Registration

09:00-09:30

Opening Ceremony and Introduction

09:30-10:10

Keynote Session I

10:10-10:50

Keynote Session II

10:50-11:00

Refreshment Break

11:00-15:00

Break Out Session I

15:00-15:10

Refreshment Break

15:10-18:00

Break Out Session II

09:30-10:10

Keynote Session III

10:10-10:50

Keynote Session IV

10:50-11:00

Refreshment Break

11:00-15:00

Break Out Session III

15:00-15:10

Refreshment Break

15:10-18:00

Break Out Session IV

Get more information

make a booking now

Market Reports

Subscribe to our News & Updates